Rocket Pharmaceuticals Inc. (RCKT)
NASDAQ · Healthcare
Rocket Pharmaceuticals Inc. Revenue 2016–2025
Rocket Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Rocket Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 0.
- Rocket Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 0.
- Rocket Pharmaceuticals Inc. annual revenue for 2025 was 0.
- Rocket Pharmaceuticals Inc. annual revenue for 2024 was 0.
- Rocket Pharmaceuticals Inc. annual revenue for 2023 was 0.
- Rocket Pharmaceuticals Inc. annual revenue for 2022 was 0.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Rocket Pharmaceuticals Inc. (RCKT) — Frequently Asked Questions
Rocket Pharmaceuticals Inc. (RCKT) is a publicly traded US company. It has a market capitalization of $289M. Explore RCKT's stock price, financial statements, earnings history, margins and key ratios below.
What is Rocket Pharmaceuticals Inc.'s market cap?
Rocket Pharmaceuticals Inc. (RCKT) has a market capitalization of $289M.
What is the RCKT stock price?
RCKT trades at $2.60 (-1.89% on the day).
Is RCKT profitable?
In fiscal 2025, Rocket Pharmaceuticals Inc. reported net income of -$223M.